業績

{ 111件 }

Yanagiya S, Nakamura K, Ukawa S, Tsutsumi A, Atsumi T, Tamakoshi A.

Household income and the risk of incident hypertension in employees at multiple workplaces in Japan: J-HOPE.

Hypertens Res. 2020 Aug 24.

IF:2.941 (2019)

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Chiho Oba-Yamamoto, Jun Takeuchi, Akinobu Nakamura, Ryoko Takikawa, Ayano Ozaki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia J Diabetes Investig, in press

IF: 3.761

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Koki Chiba, Hiroshi Nomoto, Akinobu Nakamura, Kyu Yong Cho, Kumiko Yamashita, Yui Shibayama, Aika Miya, Hiraku Kameda, Yoshio Kurihara, Shin Aoki, Tatsuya Atsumi, Hideaki Miyoshi. SGLT2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes.

J Diabetes Investig, in press

IF: 3.761

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T. Inverse correlation between serum high-molecular-weight adiponectin and proinsulin level in a Japanese

population: the DOSANCO Health Study. J Diabetes Investig, in press

IF: 3.902

 

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Takase T, Nakamura A, Miyoshi H, Koga M, Toyomaki A, Kusumi I, Kino R, Konishi Y, Kiso Y, Atsumi T.

Effects of Palmaria palmata on lipid metabolism and glycemic control in participants with hypercholesterolemia in a randomized double-blind placebo-controlled trial.
Phytother Res, in press

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

アメリカ内分泌学会  Outstanding abstract award 千葉 幸輝先生

  • 2020
  • 糖尿病・内分泌グループ
  • 受賞

令和元年度北海道科学技術奨励賞 中村 昭伸先生

  • 2020
  • 糖尿病・内分泌グループ
  • 受賞

フラテ研究奨励賞 亀田 啓先生

  • 2020
  • 糖尿病・内分泌グループ
  • 受賞

Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Shigekazu Ukawa, Koshi Nakamura, Takafumi Nakagawa, Yasuo Terauchi, Akiko Tamakoshi, Tatsuya Atsumi

Correlation between serum proinsulin levels and fatty liver: the DOSANCO Health Study

Journal of Diabetes Investigation, in press.
IF: 3.902

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Kameda R, Nomoto H, Cho KY, Kawata S, Omori K, Takeuchi J, Nagai S, Kurihara Y, Aoki S, Nakamura A, Atsumi T, Miyoshi H. 

Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicenter, prospective, randomized, open-label, blinded endpoint parallel-group comparison study.

BMJ Open. 2020

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著